Skip to Content

Clinical Trials

Please visit the following to learn more about these clinical trials.

Read about the Ovarian Cancer Low Risk Study.

  • MD Anderson Study Summary ID02-115
    A Phase II Study to Evaluate the Maximum Biologic Dose of Pegylated-Interferon (PEG INTRON) in Patients with Platinum-Resistant Ovarian, Peritoneal or Fallopian Tube Cancer

  • MD Anderson Study Summary ID02-321
    A Phase 1/2 Randomized Study of Intraperitoneal tgDCC-E1A and Intravenous Paclitaxel in Women with Platinum-Resistant Ovarian Cancer

© 2013 The University of Texas MD Anderson Cancer Center